Trial
NCT02227368
Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
CPC Clinical Research
Condition
Peripheral Artery Disease (PAD)
Intervention
Ticagrelor
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-19